Azelis Touts Cash Strength as Acquisitions Counter Market Volatility

ANTWERP, Belgium – April 23, 2026 – Azelis Group NV presented a picture of disciplined resilience in its first-quarter 2026 results, demonstrating a robust ability to generate cash and reduce debt even as overall revenue slightly declined amidst a volatile global market. The specialty chemicals and food ingredients distributor reported a marginal 0.7% revenue decrease in constant currency to EUR 1.0 billion, but the headline figures masked a more complex story of strategic acquisitions offsetting organic weakness and regional markets moving at different speeds.

The company’s leadership emphasized its asset-light business model and operational efficiency, which proved critical in a landscape marked by geopolitical tensions and uneven economic recovery. The results underscore a key strategic pillar for Azelis: navigating near-term market turbulence through financial prudence while continuing to build for long-term growth via its aggressive M&A playbook.

Financial Discipline Shines Through

While top-line revenue saw a minor dip, the standout metric in Azelis’s Q1 report was its formidable cash generation. The company delivered EUR 119 million in free cash flow, nearly matching the prior year's figure but dramatically improving its efficiency. This resulted in a free cash flow conversion ratio of 113%, a significant 13-percentage-point expansion from Q1 2025. This performance highlights the company's success in managing its working capital, which decreased to 13.9% of revenue, down from 14.7% in the prior year.

This strong cash performance allowed Azelis to continue trimming its debt for the second consecutive quarter, with net debt falling to EUR 1.5 billion. While profitability metrics like adjusted EBITA saw a contraction to EUR 104 million, the company's focus on cost discipline helped mitigate the impact of lower revenue and negative mix effects.

In her statement, Group CEO Anna Bertona commented on the company's approach: "We remain focused on disciplined execution, advancing our commercial programmes to drive growth. We are also maintaining a clear focus on supporting our customers, particularly during supply chain disruptions, while defending our position in more challenging markets." This balanced approach, she noted, positions the company to capture upside as conditions evolve.

A Tale of Two Growth Levers

Azelis’s performance reveals a dual-pronged strategy in action. On one hand, the company faced a 3.9% organic revenue decline, reflecting the soft demand and challenging conditions plaguing parts of the chemical industry. On the other hand, its well-honed acquisition strategy delivered a 3.3% contribution to revenue, almost entirely offsetting the organic shortfall.

This M&A activity is not random but a targeted effort to secure what the company calls "local champions" in high-margin niches and strategic geographies. Recent acquisitions, such as S. Amit Group in India and Solchem Nature in Spain, illustrate this playbook. These moves strengthen Azelis’s footprint in the thriving Indian domestic market and expand its higher-margin Life Sciences portfolio in Europe, respectively. The consistent execution of this strategy provides a crucial buffer against cyclical downturns and positions the company for accelerated growth when markets recover.

The company's revenue was almost evenly split between its two main segments. Life Sciences revenue remained stable in constant currency at EUR 662 million, propped up by acquisition contributions. Meanwhile, Industrial Chemicals saw a 2.1% decline in constant currency to EUR 379 million, reflecting continued demand weakness in sectors like coatings and construction.

Diverging Fortunes Across Global Regions

The quarter also highlighted a stark divergence in regional performance, painting a vivid map of global economic pressures. The Europe, Middle East, and Africa (EMEA) region, Azelis's largest market, faced the most significant challenges, posting a 9.5% organic revenue decline. This reflects a wider crisis in the European chemical sector, which is struggling with high energy costs, overcapacity, and intense competition from cheaper imports. Despite the revenue pressure, acquisitions helped limit the overall decline in EMEA to 2.3% in constant currency.

In sharp contrast, the Asia-Pacific (APAC) region emerged as a beacon of growth, delivering a solid 4.0% increase in organic revenue. This performance aligns with broader market trends identifying APAC as the fastest-growing region for specialty chemicals, driven by rapid industrialization. However, Azelis noted that negative mix effects, particularly from market weakness in the structurally higher-margin markets of Australia and New Zealand, led to a contraction in the region’s gross profit margin.

The Americas presented a middle ground, with revenue remaining broadly stable with a slight 1.2% organic decline in constant currency. The company saw some end markets stabilizing but noted that demand remains subdued in industrial applications. A significant currency headwind, however, pushed the region's reported revenue down by 8.6%.

Charting a Course Through Uncertainty

Looking ahead, Azelis management struck a tone of cautious confidence. The company acknowledged that geopolitical tensions continue to fuel market volatility and limit visibility on the pace of a sustained recovery. The press release noted that any near-term uplift from pre-buying or price inflation related to global conflicts is expected to be more moderate than in the post-Covid cycle, given a softer underlying demand environment.

Despite these headwinds, the company reiterated its belief in the long-term structural attractiveness of the specialty chemicals and food ingredients distribution market. With a clear strategy focused on disciplined cost management, strong cash generation, and strategic acquisitions, Azelis is positioning itself to not only weather the current storm but to emerge stronger. As Anna Bertona stated, "With a clear strategy and consistent execution, we are well positioned to benefit from a gradual market recovery and deliver sustainable long-term value for our stakeholders."